Skip to main content

Clayton E Mathews

NIH Rank #1089
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2238169Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Surgery
  • Biomedical Engineering
  • Microbiology & Immunology

NIH Funding · FY2026

Linked Award Amount
$3.5M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#1,089
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Clayton E Mathews. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Clayton E Mathews as a PI. Multi-PI records show the full award amount for context.

  • 2RM1GM139690-06RM1
    Renewal: Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology
    $1.8M
    award amount
  • 1R01DK147991-01R01
    Beta Cell Impairment in T1D: Insights from Glucose Metabolism in Human Pancreas Slices
    $754.7K
    award amount
  • 5R01DK135081-04R01
    Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
    $672.9K
    award amount
  • 5P01AI042288-28P01
    Immune Function and the Progression to Type 1 Diabetes
    $324.6K
    award amount

Award organization

Organizations that administered FY2026 awards listing Clayton E Mathews as a PI.

FY2026 award administered by University of Florida (FL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Florida
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2633
  6. 2024
    Entered Top 25% Nationally
    Ranked #2633
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader
  10. 2026
    Entered Top 10% Nationally
    Ranked #1089